Saliva testing is less sensitive than a nasal swab. But in the midst of a public health crisis, in some cases a test with slightly reduced sensitivity may be better than no test at all.
Academic rigor, journalistic flair
Articles on SARS-CoV-2
Displaying 1 - 20 of 187 articles
Pooled testing is most efficient when applied in settings of low virus prevalence.
Screening multiple samples with a single test gets more people diagnosed using fewer supplies. Two health policy researchers explain how it works and how it could help the U.S.
During the last six months, news reports have mentioned dozens of drugs that may be effective against the new coronavirus. Here we lay out the evidence and reveal which ones are proven to work. Or not.
The recent spike in new coronavirus cases in the US is not due to a second wave, but simply the virus moving into new populations or surging in places that opened up too soon.
If a return to the office is on the cards, both employers and employees have a role to play in minimising the risk of COVID-19 spread.
Kinases are cellular control switches. When they malfunction, they can cause cancer. The coronavirus hijacks these kinases to replicate, and cancer drugs that target them could fight COVID-19.
A simple computer model shows that safety measures can significantly impact both the exponential spread of COVID-19 and mortality rates.
China’s attempts to promote its actions and model of governance while discrediting the EU are not a short-term response to the pandemic, but part of a long-term strategy to build its international power.
Our experts offer safer ways to bring back amateur sports.
Is it possible that people who recover from COVID-19 will be plagued with long term side effects from the infection? An infectious disease physician reviews the evidence so far.
The smallpox virus appears to have been with humanity for millennia before a global vaccination drive wiped it out. Current genome research suggests how smallpox spread and where it came from.
A rare new disease syndrome appears to be caused by an overactive immune response in children, often hitting weeks after exposure to the SARS-CoV-2 virus.
There is a lot of confusion and concern around asymptomatic spread of SARS-C0V-2. An infectious disease expert explains how many people are asymptomatic and how they can spread the virus.
A mutating coronavirus has implications for vaccines, treatments, tests and your future plans.
An intriguing link could help us understand why men are at higher risk from COVID-19 than women. It also might pave the way for a potential treatment.
The body has many natural defenses against viruses and other pathogens. One antiviral molecule produced in the body is nitric oxide and it is created when we breathe in through the nose.
A century ago, the influenza pandemic killed about 50 million people. Today we are battling the coronavirus pandemic. Are we any better off? Two social scientists share five reasons we have to be optimistic.
France says one metre, Spain says two. But what really constitutes a safe distance when it comes to COVID-19?
Contact lenses are safe to use during the pandemic as long as you follow strict hygiene recommendations, including frequent hand washing.
Top contributors
-
Professor of Medicine, University of Virginia
-
Associate Professor, La Trobe University
-
Professor of Vaccinology and Director of the MRC Respiratory and Meningeal Pathogens Research Unit, University of the Witwatersrand
-
Professor and Director of Quantitative Biosciences Institute & Senior Investigator at the Gladstone Institutes, University of California, San Francisco
-
Vice-Chancellor's Research Fellow, School of Health and Biomedical Sciences, RMIT University
-
Professor and Director of Doherty Epidemiology, University of Melbourne
-
Associate Professor of Medicine, Infectious Diseases Physician, Australian National University
-
Dean of the Faculty of Commerce, Law and Management, and Head of the Southern Centre for Inequality Studies, University of the Witwatersrand
-
Professor of Infectious Diseases, University of Cape Town
-
Chair of Social Security Systems Administration and Management Studies, Adjunct Professor in the School of Governance, University of the Witwatersrand
-
Associate Professor, Cape Peninsula University of Technology
-
Epidemiologist | Senior Research Fellow, Australian National University
-
Professor and Chair of Epidemiology, University of Michigan
-
NHMRC early career fellow, The Peter Doherty Institute for Infection and Immunity
-
Assistant Professor of History, University of Pittsburgh
